Limitations of Antiarrhythmic Drugs in the Treatment of Atrial Fibrillation
12 Nov 2020
Antiarrhythmic drug (AAD) therapy aims to restore and maintain sinus rhythm in patients with atrial fibrillation (AF). They remain the main therapeutic agents to restore and maintain sinus rhythm in patients with AF. There are still questions on the efficacy, tolerability and safety of these drugs. This lecture will review the mechanism of actions of AADs, its efficacy and safety in treatment of patients with atrial fibrillation. Case based discussion will be conducted to highlight AAD considerations in the management of patients with different clinical scenarios.
After the lecture, the participants will be able to gain an understanding on:
Click here for more lecture details.
To register, scan the QR code or click on the web link. Registration closes on 29 October 2020, Thursday.
Upon registration, participants agreed to the following PGAHI Terms & Conditions.
Date:12 November 2020, Thursday
Timing:6.30 pm - 7.30 pm
Platform:Zoom Cloud Meetings
Registration Closing Date: 29 October 2020, Thursday
Zoom Capacity: 500
This lecture will be conducted via Zoom Cloud Meetings app. For ease of accessing the lecture, please download/update Zoom Cloud Meetings app. Details of the lecture meeting link will be sent to the successful registrants nearer the lecture date.